OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
March 16, 2023
Pfizer will acquire all outstanding shares of Seagen for a total of $43 billion.
March 14, 2023
Sumitovant Bipharma has completed its acquisition of Myovant Sciences for approximately $1.7 billion.
March 13, 2023
Silicon Valley Bank has collapsed, leaving many biotechnology companies unsure of the future.
March 02, 2023
Lilly will cap insulin prices for patients with and without insurance at $35 per month.
February 28, 2023
Moderna and Merck’s investigational personalized mRNA cancer vaccine has been granted Breakthrough Therapy Designation by FDA.
February 22, 2023
Pfizer reports that the combination of talazoparib and enzalutamide demonstrated statistically significant improvement in patient survival in a Phase III trial.
February 07, 2023
Naoki Okamura, Astellas’ current chief strategy officer, will take over the role from Kenji Yasukawa.
January 11, 2023
The definitive agreement will give AstraZeneca global rights to CinCor’s portfolio of cardiorenal disease treatments.
Chiesi will acquire Amryt Pharma, a commercial-stage biopharmaceutical company, in a deal worth up to $1.47 billion.
Ipsen’s $952 million acquisition of Albireo is designed to bolster the company's rare disease portfolio.